Health

Health

A Death in a CAR-T Trial Puts China's Booming Cancer-Drug Industry Under Scrutiny

A 49-year-old gastric-cancer patient died of brain hemorrhage weeks after joining a CAR-T trial at a top Shanghai hospital. Yimufeng Biotech, IPO-bound, denies the drug was to blame; his widow is pursuing a judicial appraisal over the monitoring she says failed him.

A three-year-old in Foshan spent days in paediatric intensive care with nitrite poisoning after being fed long-stored leftovers, a case doctors traced to his family's habit of saving every dish. The story has become the season's warning about a thrifty kitchen practice that food scientists have long advised against.

Health

Three Forensic Reviews, Three Verdicts: A Maternal Death Case Tests China's Medical-Accident System

A woman died after a caesarean section at a Shandong maternity hospital in 2024. Three successive forensic reviews — district, provincial and national — flipped from 'no accident' to the hospital bearing main responsibility, and this week the penalties drew national attention.